Filings

4 documents · 9 matches

1. VOR Vor Biopharma Inc. 10-Q 2025-05-14

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   going concern for a period of 12 months from the date of issuance of the accompanying condensed consolidated financial statements
   5 matches in this document Show context Copy citation

2. VOR Vor Biopharma Inc. 10-Q 2025-11-13

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   obtain sufficient additional funding, there can be no assurance that we will be able to continue as a going concern.
   1 match in this document Show context Copy citation

3. VOR Vor Biopharma Inc. 10-Q 2025-08-12

   Item 1 · Note 1. Nature of the Business

   going concern within one year after the date that the condensed consolidated financial statements are issued. As a result of the issuance
   2 matches in this document Show context Copy citation

4. VOR Vor Biopharma Inc. 8-K 2025-06-26

   going concern. These and other risks are described in greater detail under the caption “Risk Factors” included in Vor Bio’s most
   1 match in this document Show context Copy citation